July 16, 2019 – AHI participated in the FDA Center for Veterinary Medicine’s public meeting about alternative approaches in clinical investigations for new animal drugs. The meeting included four sessions that focused on the following topics: (1) complex adaptive and other novel investigation designs; (2) data from foreign countries; (3) real-world evidence; and (4) biomarkers […]
AHI Statement OnArticle 118 Trade Letter May 23, 2019 – Today, 19 agriculture and veterinary associations sent a letter to Agriculture Secretary Perdue and U.S. Trade Representative Lighthizer urging the Administration to continue placing a high priority on combating trade barriers not based on science that reduce access to modern medicines and technologies for U.S. […]
FDA Report on Sales of Antibiotics for Use in Food Producing Animals Washington, D.C., December 18, 2018 – Today’s antibiotic sales report from the Food and Drug Administration (FDA) represents the first year of implementation of the agency’s Judicious Use Program. As part of the Judicious Use Program, the animal health industry worked cooperatively with […]
Animal Disease Preparedness In The 2018 Farm Bill Washington, D.C., December 11, 2018 – The 2018 Farm Bill conference report contains important provisions to increase our country’s preparedness to respond to foreign animal disease threats. The establishment of a foot-and-mouth disease vaccine bank and increased funding for surveillance and diagnostic support through the National Animal […]
Ralph the dog, Milo the cat, and Ruby Sue the goat take home top honors Contact: Jennifer DiSiena Jennifer.DiSiena@storypartnersdc.com 516-941-6796 FOR IMMEDIATE RELEASE Washington, D.C. – (September 6, 2018) The love of animals trumped politics tonight as members of Congress and Hill staffers from both sides of the aisle gathered to celebrate pets and learn […]
The Animal Health Institute appreciates the work of Chairman Burgess, ranking member Green and the Energy and Commerce Health Subcommittee in moving the Animal Drug and Generic Animal Drug User Fee Amendments of 2018 toward Congressional approval. We also thank Representative Mullin and Representative Schrader for sponsoring this important legislation. The animal drug user fee […]
Washington, DC – December 7, 2017 – Antibiotic sales – whether they go up or down – are not predictors of public health impact. While today’s sales report is an interesting piece of the story, we are more encouraged by the recent data from the National Antimicrobial Resistance Monitoring System that shows that for those pathogens that might transfer from animals to humans, resistance rates in people have been stable or declining.
AHI Lauds Funding of Antibiotic Data Collection USDA program supported by wide variety of stakeholders Washington, D.C., May 4, 2017 – The Animal Health Institute today praised Congressional appropriators for including money for antibiotic data collection in the Continuing Resolution for Fiscal Year 2017. The budget agreement contains $7 million for the U.S. Department of […]
New article in Critical Reviews in Food Science and Nutrition highlights results from a systematic review of salmonellosis studies Washington, DC [February 24, 2017] – A team of interdisciplinary scientists at the Medical University of South Carolina and the Charleston VA Medical Center Research Service recently reviewed published literature for evidence of a relationship between […]
February 2, 2017 Mariette DeChristina Editor in Chief Scientific American Dear. Ms. DiChristina: I am writing to express our surprise and disappointment with your recent article “How Drug-Resistant Bacteria Travel from the Farm to Your Table” written by Melinda Wenner Moyer. The issue of antibiotic resistance is a scientifically technical and nuanced issue with […]
About Animal Health Institute
The Animal Health Institute (AHI) represents the companies that develop and produce animal medicines. Our industry is a global leader whose products improve the health of nearly 10 billion companion and food-producing animals in the U.S., which results in significant economic and social benefits for Americans.